drugset / Trial / NCT06708611
A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a randomized double-blind crossover study of the patients with stable heart failure, who are taking a loop diuretic. During the study period, the participants' loop diuretics will be replaced by the equivalent dose of immediate release/extended release torsemide for one week. After a one week period, they will report to the site and will receive a single dose of either immediate release or extended release Torsemide. The sodium excretion will be measured for six hours after dosing and for an additional six hours after a high salt lunch.
Timeline
- Start
- 2025-01-15
- Primary completion
- 2025-03-25
- Completion
- 2025-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Torsemide | Other / unclassified | 20 mg | Oral |
| Subject | Torsemide | Other / unclassified | 24 mg | Oral |